In the News

Share

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
COVID-19: Information for Patients and Caregivers

We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.

What you need to know

1730 News Items found
detail shot of specimen slides
MSK Research Highlights, July 8, 2024

New MSK research developed a deep-learning model designed to aid challenging cancer diagnoses; identified key regulators of infection-clearing immune cells; and shed new light on the mechanical forces exerted by immune cells.
Feature
MSK melanoma expert James Smithy, MD
New Treatments Improving Prognosis for Stage 4 Melanoma Patients

Researchers at MSK have been at the forefront of developing new treatments for advanced melanoma for many years. Learn more about the latest therapies.
In the Lab
Cyclotron engineer and nuclear pharmacist
New Imaging Detects Deadly Lung and Prostate Cancers, May Improve Treatment

Learn how a new imaging technique could improve detection and treatment of certain aggressive lung and prostate cancers.
Close-up of two people holding hands
Coping With Grief: 7 Things to Remember When Dealing with Loss

Grief can feel all-consuming, but those intense feelings don’t last forever.
Q&A
Dr. Helena Yu
Lung Cancer in Women and Nonsmokers: What To Know About Symptoms, Diagnosis, and Treatment

Learn about lung cancer in women, the links between lung cancer and smoking, the relationship between lung cancer and genetics, and the benefits of being treated at a hospital that offers many clinical trials for lung cancer.
A researcher pipettes in the lab
MSK Research Highlights, June 25, 2024

New MSK research helped develop a machine-learning tool to help find cancer cells that remain after surgery; led to FDA approval for CAR T cell therapy against mantle cell lymphoma; tested a liquid biopsy approach that shows promise in detecting lung cancer; found checkpoint inhibitors were effective against endometrial and ovarian cancers with DNA-repair deficiency; and shed new light on mTOR's role in metabolic enzyme degradation.
In the Clinic
Cannabis oil is often heralded as an alternative cure for cancer
The Truth Behind Four Natural Cancer “Cures”

The internet is full of “miracle cures” for cancer and alleged surefire ways to prevent it, and well-meaning people may urge cancer patients to just tr...
Dr. Mara Sherman in her lab, with two trainees working in the background
Into the Matrix: MSK’s Mara Sherman is Unlocking the Secrets of the Fibrotic Fortress that Surrounds and Protects Pancreatic Cancer

Dr. Mara Sherman's lab at the Sloan Kettering Institute is “all pancreas, all the time.” Learn how her research program is illuminating interactions between cancer cells and the dense weave of fibrous cells that surrounds and protects pancreatic tumors.
Dr. Rona Yaeger
FDA Approves First Colorectal Cancer Treatment that Targets KRAS Gene

The targeted therapy adagrasib received accelerated approved for colorectal cancer caused by a mutation called KRAS-G12C, when used in combination with the drug cetuximab. MSK investigators have led much of the research that resulted in this combined drug approval.
Joseph Sun and Rebecca Delconte
Fasting Primes the Immune System’s Natural Killer Cells to Better Fight Cancer, New Study in Mice Finds

Animal model research from MSK has shown for the first time that fasting can reprogram the metabolism of natural killer cells, helping them to survive in the harsh environment in and around tumors, while also improving their cancer-fighting ability.